ASCO frequently highlights the work of State Affiliates in The ASCO Post. The most recent state society to be featured is the Maryland/D.C. Society of Clinical Oncology. Here is an excerpt from the May 10, 2015 article in The ASCO Post:
"In March 2013, 60 Minutes aired a devastating piece about a Massachusetts compounding center that shipped an injectable steroid contaminated with fungus. One of the many ripple effects from this story of horrendous patient suffering was felt in Maryland, where it sparked legislative action in the Annapolis State House."
Read the article featuring the Maryland/D.C. Society of Clinical Oncology.
Previous issues of The ASCO Post featuring ASCO Affiliates:
- Maryland/D.C. Society of Clinical Oncology (5/10/15)
- Florida Society of Clinical Oncology (8/15/14)
- Ohio Hematology Oncology Society (7/25/14)
- Washington State Medical Oncology Society (6/25/14)
- Connecting to ASCO Through the State Affiliate Council (4/15/14)
- Virginia Association of Hematologists and Oncologists (3/15/14)
- Michigan Society of Hematology and Oncology (2/15/14)
- Massachusetts Society of Clinical Oncologists (12/15/13)
- Texas Society of Clinical Oncology (11/15/13)
- Wisconsin Association of Hematology and Oncology (10/15/13)
- West Virginia Oncology Society (8/15/13)
- Society of Rhode Island Clinical Oncologists (7/10/13)
- Georgia Society of Clinical Oncology (6/25/13)
- Delaware Society for Clinical Oncology (6/10/13)
- Denali Oncology Group (5/15/13)
- Louisiana Oncology Society (4/15/13)
- Medical Oncology Association of Southern California (3/15/13)
If your society is interested in being featured in The ASCO Post, please contact Melissa.Reifler@asco.org.
In the past, the ASCO State/Regional Affiliate Program partnered with ASCO Connection to present a bimonthly, online column titled "Spotlight on State Affiliates" to increase awareness of the important work being pursued by ASCO State/Regional Affiliates.
The Michigan Society of Hematology and Oncology was the last Affiliate to be featured.
"The Michigan Society of Hematology and Oncology (MSHO) was formed in 1985 in response to unfavorable changes in Medicare reimbursement and consistent coverage issues with Michigan's private payers that jeopardized the specialists' ability to deliver quality care. Twenty seven years later, the need to advocate for the advancement of cancer treatment as a recognized, credible, unified, local "Voice of Oncology" remains."